Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 824

Related Citations for PubMed (Select 16012271)

1.

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.

Potkin SG, Keck PE Jr, Segal S, Ice K, English P.

J Clin Psychopharmacol. 2005 Aug;25(4):301-10.

PMID:
16012271
2.

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.

Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K; Ziprasidone in Mania Study Group.

Am J Psychiatry. 2003 Apr;160(4):741-8.

PMID:
12668364
3.

Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.

Keck PE Jr, Versiani M, Warrington L, Loebel AD, Horne RL.

J Clin Psychiatry. 2009 Jun;70(6):844-51.

PMID:
19573482
4.

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.

Hirschfeld RM, Keck PE Jr, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F.

Am J Psychiatry. 2004 Jun;161(6):1057-65.

PMID:
15169694
5.

Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.

Keck PE Jr, Reeves KR, Harrigan EP; Ziprasidone Study Group.

J Clin Psychopharmacol. 2001 Feb;21(1):27-35.

PMID:
11199944
6.

Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.

Ketter TA, Agid O, Kapur S, Loebel A, Siu CO, Romano SJ.

J Psychiatr Res. 2010 Jan;44(1):8-14. doi: 10.1016/j.jpsychires.2009.07.006. Epub 2009 Aug 21.

PMID:
19699488
7.
8.

The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.

Harvey PD, Endicott JM, Loebel AD.

Bipolar Disord. 2008 Dec;10(8):900-6. doi: 10.1111/j.1399-5618.2008.00634.x.

PMID:
19594505
9.

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

OliƩ JP, Spina E, Murray S, Yang R.

Int Clin Psychopharmacol. 2006 May;21(3):143-51.

PMID:
16528136
10.

Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.

Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter TA, Keck PE, Swann A, Kalali A; SPD417 Study Group.

CNS Drugs. 2006;20(3):219-31.

PMID:
16529527
11.

Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.

Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.

Clin Ther. 2011 Nov;33(11):1643-58. doi: 10.1016/j.clinthera.2011.10.002. Epub 2011 Nov 4.

PMID:
22054797
12.

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.

J Affect Disord. 2008 Jan;105(1-3):101-8. Epub 2007 May 24.

PMID:
17531327
14.

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.

Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J.

Am J Psychiatry. 2005 Jul;162(7):1351-60.

PMID:
15994719
15.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
16.

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.

McIntyre RS, Konarski JZ, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S5-14. Epub 2007 Mar 27.

PMID:
17391773
18.
19.

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.

Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM.

Int Clin Psychopharmacol. 2006 Jan;21(1):11-20.

PMID:
16317312
20.

A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.

Kinon BJ, Lipkovich I, Edwards SB, Adams DH, Ascher-Svanum H, Siris SG.

J Clin Psychopharmacol. 2006 Apr;26(2):157-62.

PMID:
16633144
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk